To block protein-antibody complex formation during immunochemical analysis of the EP2 receptor
Related Products
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

EP2 Receptor Blocking Peptide

Item No. 301750

Technical Information
Synonyms
  • PGE2 Receptor 2
  • Prostaglandin E2 Receptor 2
A lyophilized peptide
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    Each vial contains 200 µg of lyophilized peptide derived from the human EP2 receptor sequence (C-terminal amino acids 335-358; SLRTQDATQTSCSTQSDASKQADL).1 This peptide was used as an antigen for production of the EP2 receptor polyclonal antibody (Catalog No. 101750) and can be used in conjunction with this antibody to block protein-antibody complex formation during immunochemical analysis for the EP2 receptor. The biological effects of prostaglandin E2 (PGE2) are mediated through interaction with four distinct membrane-bound G-protein coupled EP receptors: EP1, EP2, EP3, and EP4.2,3 Binding of PGE2 to the EP2 receptor results in an increase in adenylate cyclase activity with a subsequent increase in cAMP.1,4 Pharmacologically, EP2 receptors mediate relaxation of smooth muscle and are distinguished from EP4 receptors by their sensitivity to the EP2 receptor selective agonist butaprost.2,3,1 The human EP2 receptor is comprised of 358 amino acids with a molecular mass of approximately 40,000.1 A band at 53 kDa is detected in most samples by western blotting. mRNA for the EP2 receptor is expressed in a variety of tissues including lung, placenta, spleen, intestine, kidney, and sensory neuron.1,4,5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Regan, J.W., Bailey, T.J., Pepperl, D.J., et alCloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. Mol. Pharmacol. 46(2), 213-220 (1994).

    2. Coleman, R.A., Smith, W.L., and Narumiya, S. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46(2), 205-229 (1994).

    3. Coleman, R.A., Dahlén, S.E., Drazen, J.M., et alClassification of leukotriene receptors IUPHAR receptor compendium. IUPHAR Compendium 1-7 (1997).

    4. Nemoto, K., Pilbeam, C.C., Bilak, S.R., et alMolecular cloning and expression of a rat prostaglandin E2 receptor of the EP2 subtype. Prostaglandins 54(4), 713-725 (1997).

    5. Southall, M.D., and Vasko, M.R. Prostaglandin receptor subtypes, EP3C and EP4, mediate the prostaglandin E2-induced cAMP production and sensitization of sensory neurons. The Journal of Biological Chemisty 276(19), 16083-16091 (2001).